GDX_Logos_Blue_211220_01_600x208.jpg
Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance
January 09, 2023 08:30 ET | GeneDx Holdings Corp.
Company expects to exceed 2022 revenue target with strong momentum to deliver continued growth in 2023 combining GeneDx and Centrellis® platforms Company’s common stock will trade on the Nasdaq under...
22157.jpg
Direct-To-Consumer (DTC) Genetic Testing Market Report 2022: Featuring 23 and Me, Gene by Gene, Quest Diagnostics & More
December 16, 2022 08:03 ET | Research and Markets
Dublin, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The "Direct-To-Consumer (DTC) Genetic Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
WellSpan Health and
WellSpan Health and Helix announce partnership to improve patient health outcomes through new population genomics program
December 08, 2022 08:50 ET | WellSpan Health
York, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- WellSpan Health and Helix, the nation’s leading population genomics and viral surveillance company, announced today a partnership to create a...
22157.jpg
Genome Engineering Global Market Report 2022: Increasing Funding and Investments for Research and Development Present Lucrative Opportunities
December 08, 2022 06:08 ET | Research and Markets
Dublin, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The "Genome Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technology (CRISPR, TALEN, ZFN,...
Global Epigenetics Market
Epigenetics Global Market Report 2022: Increasing Investment and R&D Efforts Driving Growth
December 06, 2022 05:53 ET | Research and Markets
Dublin, Dec. 06, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
Sema4_Logo2021_Primary_Gradient.png
New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICU
December 05, 2022 08:00 ET | Sema4
STAMFORD, Conn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the results of a new study on mitochondrial diseases in newborns. The findings...
22157.jpg
Global RNA Sequencing Services Markets, 2022-2035: 340+ Patents Related to RNA Sequencing have Been Recently Filed/Granted, Demonstrating the Innovation and Continuous Research Efforts in this Domain
November 25, 2022 08:48 ET | Research and Markets
Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) -- The "RNA Sequencing Services Market: Distribution by Type of Sequencing Method, Application Area, End User Industry and Key Geographical Regions: Industry...
Global Metagenomics Market
Metagenomics Global Market Report 2022: Rising Demand for Effective Solutions for the Timely Diagnosis of Neuroinfectious Diseases Drives Growth
November 23, 2022 07:33 ET | Research and Markets
Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The "Metagenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Epigenetics Market
Global Epigenetics (Reagents, Enzymes, Instruments, Kits) Market Research Report 2022: A $14.79 Billion Market in 2026 - Long-term Forecasts to 2031
November 22, 2022 06:05 ET | Research and Markets
Dublin, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global epigenetics market is expected to grow...
Global Pharmacogenomics Market
Global Pharmacogenomics Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F: Focus on Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray
November 11, 2022 06:28 ET | Research and Markets
Dublin, Nov. 11, 2022 (GLOBE NEWSWIRE) -- The "Pharmacogenomics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global pharmacogenomics market is expected...